Effects of allopurinol and vitamin E on renal function in patients with cardiac coronary artery bypass grafts

Vascular Health and Risk Management

Volumn 5, Issue , 2009, Pages 489-494

  Nouri Majalan, Nader ^a   Ardakani, Ehsan Fotouhi ^b   Forouzannia, Khalil ^a   Moshtaghian, Hosein ^a  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Antioxidants; Coronary artery bypass; Prevention and control; Renal function

Indexed keywords

ALLOPURINOL; ALPHA TOCOPHEROL; CREATININE; POTASSIUM; ANTIMETABOLITE; ANTIOXIDANT;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; POTASSIUM BLOOD LEVEL; PREOPERATIVE EVALUATION; RANDOMIZED CONTROLLED TRIAL; DRUG EFFECT; KIDNEY; KIDNEY FUNCTION TEST; MIDDLE AGED;

AGED; ALLOPURINOL; ANTIMETABOLITES; ANTIOXIDANTS; CORONARY ARTERY BYPASS; FEMALE; HUMANS; KIDNEY; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; LENGTH OF STAY; MALE; MIDDLE AGED; VITAMIN E;

EID: 70149086151     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/vhrm.s5761     Document Type: Article

References (55)

1. Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol. 2005;16(1):162-168.
2. Cahill CJ. Prevention of postoperative renal failure in patients with obstructive jaundice - the role of bile salts. Br J Surg. 1983;70(10):590-595.
3. Gornick CC Jr, Kjellstrand CM. Acute renal failure complicating aortic aneurysm surgery. Nephron. 1983;35(3):145-157.
4. Gerritsen WB, van Boven WJ, Driessen AH, Haas FJ, Aarts LP. Off-pump versus on-pump coronary artery bypass grafting: oxidative stress and renal function. Eur J Cardiothorac Surg. 2001;20(5):923-929.
5. Kohan DE. Endothelins in the kidney: physiology and pathophysiology. Am J Kidney Dis. 1993;22(4):493-510.
6. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med. 1998;128(3):194-203.
7. Thakar CV, Worley S, Arrigain S, Yared JP, Paganini EP. Influence of renal dysfunction on mortality after cardiac surgery: modifying effect of preoperative renal function. Kidney Int. 2005;67(3):1112-1119.
8. Conger J. Hemodynamic factors in acute renal failure. Adv Ren Replace Ther. 1997;4(2 Suppl 1):25-37.
9. Verbeke M, Van de Voorde J, de Ridder L, Lameire N. Influence of ketanserin on experimental loss of renal blood flow autoregulation. Kidney Int Suppl. 1998;67:S238-S241.
10. Gellai M, Jugus M, Fletcher T, et al. Nonpeptide endothelin receptor antagonists. V: Prevention and reversal of acute renal failure in the rat by SB 209670. J Pharmacol Exp Ther. 1995;275(1):200-206.
11. Chan L, Chittinandana A, Shapiro JI, Shanley PF, Schrier RW. Effect of an endothelin-receptor antagonist on ischemic acute renal failure. Am J Physiol. 1994;266:F135-F138.
12. Gellai M, Jugus M, Fletcher T, DeWolf R, Nambi P. Reversal of postischemic acute renal failure with a selective endothelinA receptor antagonist in the rat. J Clin Invest. 1994;93(2):900-906.
13. Erley CM. Does hydration prevent radiocontrast-induced acute renal failure? Nephrol Dial Transplant. 1999;14(5):1064-1066.
14. Erley CM, Duda SH, Rehfuss D, et al. Prevention of radiocontrast-media- induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline. Nephrol Dial Transplant. 1999;14(5):1146-1149.
15. Koch JA, Plum J, Grabensee B, Mödder U. Prostaglandin E1: a new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media? PGE1 Study Group. Nephrol Dial Transplant. 2000;15(1):43-49.
16. Lee MR. Dopamine and the kidney: ten years on. Clin Sci (Lond). 1993;84(4):357-375.
17. Aperia A. Dopamine action and metabolism in the kidney. Curr Opin Nephrol Hypertens. 1994;3(1):39-45.
18. Denton MD, Chertow GM, Brady HR. "Renal-dose" dopamine for the treatment of acute renal failure: scientific rationale, experimental studies and clinical trials. Kidney Int. 1996;50(1):4-14.
19. Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol. 2000;11(1):97-104.
20. Rabb H, Postler G. Leucocyte adhesion molecules in ischaemic renal injury: kidney specific paradigms? Clin Exp Pharmacol Physiol. 1998;25(3-4):286-291.
21. De Greef KE, Ysebaert DK, Ghielli M, et al. Neutrophils and acute ischemia-reperfusion injury. J Nephrol. 1998;11(3):110-122.
22. Bonventre JV, Kelly KJ. Adhesion molecules and acute renal failure. Adv Nephrol Necker Hosp. 1996;25:159-176.
23. López-Novoa JM. Potential role of platelet activating factor in acute renal failure. Kidney Int. 1999;55(5):1672-1682.
24. Grino JM. BN 52021: a platelet activating factor antagonist for preventing post-transplant renal failure. A double-blind, randomized study. The BN 52021 Study Group in Renal Transplantation. Ann Intern Med. 1994;121(5):345-347.
25. Kohda Y, Chiao H, Star RA. Alpha-Melanocyte-stimulating hormone and acute renal failure. Curr Opin Nephrol Hypertens. 1998;7(4):413-417.
26. Chiao H, Kohda Y, McLeroy P, Craig L, Housini I, Star RA. Alphamelanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest. 1997;99(6):1165-1172.
27. Coghlan JG, Flitter WD, Clutton SM, et al. Allopurinol pretreatment improves postoperative recovery and reduces lipid peroxidation in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1994;107(1):248-256.
28. Zager RA, Fuerstenberg SM, Baehr PH, Myerson D, Torok-Storb B. An evaluation of antioxidant effects on recovery from postischemic acute renal failure. J Am Soc Nephrol. 1994;4(8):1588-1597.
29. Forde P, Scribner AW, Dial R, Loscalzo J, Trolliet MR. Prevention of hypertension and renal dysfunction in Dahl rats by alpha-tocopherol. J Cardiovasc Pharmacol. 2003;42(1):82-88.
30. Tepel M, van der Giet M, Zidek W. Antioxidant therapy in vascular and renal diseases. Med Klin (Munich). 2002;97(3):144-151.
31. Durak I, Ozbek H, Karaayvaz M, Oztürk HS. Cisplatin induces acute renal failure by impairing antioxidant system in guinea pigs: effects of antioxidant supplementation on the cisplatin nephrotoxicity. Drug Chem Toxicol. 2002;25(1):1-8.
32. Akpolat T, Akpolat I, Oztürk H, et al. Effect of vitamin E and pentoxifylline on glycerol-induced acute renal failure. Nephron. 2000;84(3):243-247.
33. Zurovsky Y, Eligal Z, Grossman S. Unilateral renal ischemia reperfusion in the rat: effect of blood volume trapped in the kidney, sucrose infusion, and antioxidant treatments. Exp Toxicol Pathol. 1995;47(6):471-478.
34. Roberts LJ 2nd, Oates JA, Linton MF, et al. The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radic Biol Med. 2007;43(10):1388-1393.
35. Ristikankare A, Kuitunen T, Kuitunen A, et al. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery. Br J Anaesth. 2006;97(5):611-616.
36. Haase M, Haase-Fielitz A, Bagshaw SM, et al. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients. Crit Care Med. 2007;35(5):1324-1331.
37. Komisarof JA, Gilkey GM, Peters DM, Koudelka CW, Meyer MM, Smith SM. N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure (NEPHRON). Crit Care Med. 2007;35(2):435-441.
38. Hynninen MS, Niemi TT, Pöyhiä R, et al. N-acetylcysteine for the prevention of kidney injury in abdominal aortic surgery: a randomized, double-blind, placebo-controlled trial. Anesth Analg. 2006;102(6):1638-1645.
39. Bolcal C, Akay HT, Bingol H, et al. Leukodepletion improves renal function in patients with renal dysfunction undergoing on-pump coronary bypass surgery: a prospective randomized study. Thorac Cardiovasc Surg. 2007;55(2):89-93.
40. Kaya K, O uz M, Akar AR, et al. The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial. Eur J Cardiothorac Surg. 2007;31(2):290-297.
41. Marathias KP, Vassili M, Robola A, Alivizatos et al. Preoperative intravenous hydration confers renoprotection in patients with chronic kidney disease undergoing cardiac surgery. Artif Organs. 2006;30(8):615-621.
42. Piper SN, Kumle B, Maleck WH, et al. Diltiazem may preserve renal tubular integrity after cardiac surgery. Can J Anaesth. 2003;50(3):285-292.
43. Tataranni G, Malacarne F, Farinelli R, et al. Beneficial effects of verapamil in renal-risk surgical patients. Ren Fail. 1994;16(3):383-390.
44. Halpenny M, Lakshmi S, O'Donnell A, O'Callaghan-Enright S, Shorten GD. Fenoldopam: renal and splanchnic effects in patients undergoing coronary artery bypass grafting. Anaesthesia. 2001;56(10):953-960.
45. Tang AT, El-Gamel A, Keevil B, Yonan N, Deiraniya AK. The effect of 'renal-dose' dopamine on renal tubular function following cardiac surgery: assessed by measuring retinol binding protein (RBP). Eur J Cardiothorac Surg. 1999;15(5):717-722.
46. Baldwin L, Henderson A, Hickman P. Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery. Ann Intern Med. 1994;120(9):744-747.
47. Kulka PJ, Tryba M, Zenz M. Preoperative alpha2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: results of a randomized, controlled trial. Crit Care Med. 1996;24(6):947-952.
48. Bertolissi M, Antonucci F, De Monte A, Padovani R, Giordano F. Effects on renal function of a continuous infusion of nifedipine during cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1996;10(2):238-242.
49. Caimmi PP, Pagani L, Micalizzi E, et al. Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2003;17(4):491-494.
50. Burns KE, Chu MW, Novick RJ, et al. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: a randomized controlled trial. JAMA. 2005;294(3):342-350.
51. Bartels M, Biesalski HK, Engelhart K, Sendlhofer G, Rehak P, Nagel E. Pilot study on the effect of parenteral vitamin E on ischemia and reperfusion induced liver injury: a double blind, randomized, placebocontrolled trial. Clin Nutr. 2004;23(6):1360-1370.
52. Goode HF, Cowley HC, Walker BE, Howdle PD, Webster NR. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med. 1995;23(4):646-651.
53. Remer KA, Pfister H, Fatzer R, Leib SL, Jungi TW. The role of nitric oxide in Listeria encephalitis of ruminants and in rats intracisternally infected with Listeria monocytogenes. Berl Munch Tierarztl Wochenschr. 2002;115(7-8):259-266.
54. Lee HY, Pang SM, Thamotharampillai T. Allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis. J Am Acad Dermatol. 2008;59(2):352-353.
55. Lundberg GD. Antioxidant supplements found not to improve human survival. Medscape J Med. 2008;10(9):222.